Dow Up 0.51% Nasdaq Up 0.24%

Incyte Corporation (INCY)

-NasdaqGS
72.27 Up 0.66(0.92%) Nov 21, 4:00PM EST
|After Hours : 72.27 0.00 (0.00%) Nov 21, 7:44PM EST
Prev Close:71.61
Open:72.50
Bid:N/A
Ask:72.27 x 500
1y Target Est:81.08
Beta:0.18
Earnings Date:Feb 10 - Feb 16 (Est.)
Day's Range:71.64 - 73.15
52wk Range:40.30 - 73.15
Volume:725,012
Avg Vol (3m):1,132,720
Market Cap:12.21B
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYUp 0.92%12.21B
AMGNUp 0.08%123.84B
CELGUp 0.79%86.42B
RHHBYDown 1.04%253.38B

Key Statistics

Forward P/E (1 yr):344.14
P/S (ttm):24.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.12
Quarterly EPS Est (Dec-14) :-0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-7.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback